COVID-19: Regulator approves vaccine boosters for immuno-compromised people

*United States Food and Drug Administration (FDA) says the approval applies to several millions of consumers who may be especially vulnerable because of organ transplants, battles with cancer, or other chronic health conditions

Isola Moses | ConsumerConnect

The United States Food and Drug Administration (FDA) has approved COVID-19 booster shots for patients, who have chronic conditions that may compromise their immune systems, otherwise called the immuno-compromised people.

ConsumerConnect reports Acting FDA Commissioner Dr. Janet Woodcock said that “the country (US) has entered yet another wave of the COVID-19 pandemic, and the FDA is especially cognizant that immuno-compromised people are particularly at risk for severe disease.”

Dr. Woodcock stated: “After a thorough review of the available data, the FDA determined that this small, vulnerable group may benefit from a third dose of the Pfizer-BioNTech or Moderna Vaccines.”

It was gathered the approval applies to several million Americans who may be especially vulnerable because of organ transplants, battles with cancer, or other conditions.

In allowing some to get booster shots, the US is following the lead of some other countries, including Israel and France, agency report also said.

Meanwhile, Coronavirus‌ ‌(COVID-19)‌ ‌tally‌ ‌as‌ ‌‌compiled‌‌ ‌by‌ ‌Johns‌ ‌Hopkins‌ ‌University, indicated that total‌ ‌cases in the United States as of afternoon Saturday, August 14, 2021, were estimated at 36,326,952 with total‌ 619,200 deaths in the country.

Globally, total‌ across the world were also estimated at 205,752,476 while the total‌ ‌‌deaths hit 4,340,137 across the world.‌